Literature DB >> 10390413

Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients.

B Agerberth1, J Grunewald, E Castaños-Velez, B Olsson, H Jörnvall, H Wigzell, A Eklund, G H Gudmundsson.   

Abstract

Antibacterial peptides and proteins are an integral part of the epithelial defense barrier that provides immediate protection against bacterial invasion. In humans, alpha-defensins are mainly bactericidal effectors in circulating granulocytes, beta-defensin-1 is synthesized in epithelial cells, and LL-37 is produced in granulocytes but is also induced in skin epithelia during inflammation. To investigate the importance of these defense effectors in disease, we analyzed bronchoalveolar lavage fluid (BALF) for bactericidal activity. Antibacterial activity was found in BALF material from healthy individuals and sarcoidosis patients, with enhanced activity in BALF from the patients. The activity was present as several antibacterial components, of which we have so far characterized LL-37, lysozyme, alpha-defensins, and antileukoprotease. In addition, the antibacterial peptide LL-37 was located in alveolar macrophages, bronchial epithelial cells, and bronchial glands, suggesting that it has a defensive role in airway mucosa. In conclusion, the airway epithelium is protected by a complex antibacterial defense system. This is activated in sarcoidosis, and may explain why these patients seldom develop severe respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390413     DOI: 10.1164/ajrccm.160.1.9807041

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.

Authors:  Linda A Stevens; Joseph T Barbieri; Grzegorz Piszczek; Amy N Otuonye; Rodney L Levine; Gang Zheng; Joel Moss
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 3.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

5.  Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.

Authors:  Miguel A Campos; Miguel A Vargas; Verónica Regueiro; Catalina M Llompart; Sebastián Albertí; José A Bengoechea
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

Review 7.  Host defense peptides in the oral cavity and the lung: similarities and differences.

Authors:  G Diamond; N Beckloff; L K Ryan
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

8.  Mouse Bone Marrow Sca-1+ CD44+ Mesenchymal Stem Cells Kill Avirulent Mycobacteria but Not Mycobacterium tuberculosis through Modulation of Cathelicidin Expression via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway.

Authors:  Sumanta Kumar Naik; Avinash Padhi; Geetanjali Ganguli; Srabasti Sengupta; Sanghamitra Pati; Dasarathi Das; Avinash Sonawane
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

9.  Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.

Authors:  David Moranta; Verónica Regueiro; Catalina March; Enrique Llobet; Javier Margareto; Eider Larrarte; Eider Larrate; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 10.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.